Evidence map›Paper›PMID 37558818›Full record

ReviewOphthalmology and therapy2023

New Devices in Glaucoma.

Lilian Chan, Marlene R Moster, Amanda K Bicket, Arsham Sheybani, Steven R Sarkisian, Thomas W Samuelson, Iqbal Ike K Ahmed, Eydie Miller-Ellis, Oluwatosin U Smith, Qi N Cui

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Ophthalmology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Lilian ChanDepartment of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.
Marlene R MosterWills Eye Hospital, 840 Walnut St, Philadelphia, PA, 19107, USA.
Amanda K BicketKellogg Eye Center, Department of Ophthalmology and Visual Sciences, Medical School, University of Michigan, 1000 Wall St, Ann Arbor, MI, 48105, USA.
Arsham SheybaniWashington University School of Medicine, 660 South Euclid Ave, Campus Box 8096, St Louis, MO, 63110, USA.
Steven R SarkisianOklahoma Eye Surgeons, 5600 N Portland Ave, Oklahoma City, OK, 73112, USA.
Thomas W SamuelsonMinnesota Eye Consultants, University of Minnesota, 909 Fulton St SE, Minneapolis, MN, 55455, USA.
Iqbal Ike K AhmedDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
Eydie Miller-EllisDepartment of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.
Oluwatosin U Smith *Glaucoma Associates of Texas, 10740 N. Central Expy, Suite 300, Dallas, TX, 75231, USA.
Qi N Cui *Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA. qi.cui@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-5338-0401
Penn Presbyterian Medical Center · USGlaucoma Associates of Texas · USNorthwest Eye Surgeons · USUniversity of Michigan · USUniversity of Minnesota · USUniversity of Toronto · CAWashington University in St. Louis · USWills Eye Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm's canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.

Indexed as

Delayed-action preparationExcimer laser trabeculostomyGlaucomaGlaucoma drainage implantsiDOSEMINIjectMinimally invasive glaucoma surgeryMinimally invasive micro sclerostomyMulti-pressure dialVisiplate

Identifiers

PMID37558818
PMCPMC10441989
OpenAlexW4385693076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.